Seek Returns

ABBV vs. AMZN: AbbVie vs. Amazon.com Stock Comparison

How do AbbVie (ABBV) and Amazon.com (AMZN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Amazon.com (AMZN) belongs to Consumer Discretionary (Consumer Discretionary Distribution & Retail) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Amazon.com (AMZN)
Profile ItemABBVAMZN
NameAbbVie Inc.Amazon.com Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareConsumer Discretionary
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesConsumer Discretionary Distribution & Retail
GICS IndustryBiotechnologyBroadline Retail
GICS Sub-IndustryBiotechnologyBroadline Retail
Market Capitalization514.92 billion USD2,803.85 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJanuary 2, 2013May 15, 1997
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

ABBV
AMZN
GSPC
Loading price history…
AbbVie (ABBV) vs. Amazon.com (AMZN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and Amazon.com (AMZN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and Amazon.com (AMZN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Total Return (1Y)37.33%9.80%
Total Return (3Y, Annualized)32.74%24.05%
Total Return (5Y, Annualized)24.73%8.46%

Risk Profile

Drawdown History

ABBV
AMZN
GSPC
Loading price history…
AbbVie (ABBV) vs. Amazon.com (AMZN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and Amazon.com (AMZN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Amazon.com (AMZN) has an aggressive beta of 1.45, indicating higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Volatility (1Y, Annualized)25.65%34.10%
Beta (5Y)0.211.45
Max Drawdown (5Y)-21.92%-55.73%
Avg. Volume (3M)4.76M38.50M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and AMZN are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Sharpe Ratio (1Y)1.290.16
Sortino Ratio (1Y)2.020.26

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Amazon.com (AMZN) earns 27.42% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

AMZN

Consumer Discretionary Distribution & Retail industry group

27.42%

Max
62.17%
Q3
29.44%
AMZN
27.42%
Median
15.69%
Q1
6.73%
Min
-12.16%
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): ABBV does not report ROE, so it has no value marker; AMZN is benchmarked against the Consumer Discretionary Distribution & Retail industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and Amazon.com (AMZN) at 16.90% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

AMZN

Consumer Discretionary Distribution & Retail industry group

16.90%

Max
16.94%
AMZN
16.90%
Q3
8.69%
Median
3.55%
Q1
1.14%
Min
-9.41%
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Operating Margin (TTM)

Both AbbVie (ABBV) at 39.59% and Amazon.com (AMZN) at 13.90% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

AMZN

Consumer Discretionary Distribution & Retail industry group

13.90%

Max
21.45%
AMZN
13.90%
Q3
10.89%
Median
5.57%
Q1
2.28%
Min
-7.12%
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
ROE (TTM)--27.42%
ROA (TTM)10.74%6.62%
Net Margin (TTM)15.67%16.90%
Operating Margin (TTM)39.59%13.90%
Gross Margin (TTM)73.72%51.37%

Growth

Revenue Growth

Amazon.com (AMZN) at 12.38% sits in the top revenue growth quartile, while AbbVie (ABBV) at 8.57% is closer to the peer norm — faster top-line expansion for AMZN.

Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Amazon.com (AMZN) at 29.66% sits in the top EPS growth quartile, while AbbVie (ABBV) at -0.84% is closer to the peer norm — faster per-share earnings growth for AMZN.

Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Revenue Growth (YoY)8.57%12.38%
Revenue Growth (3Y CAGR)1.75%11.73%
EPS Growth (YoY)-0.84%29.66%
EPS Growth (3Y CAGR)-29.03%--

Financial Strength

Current Ratio (MRQ)

Both AbbVie (ABBV) at 0.87 and Amazon.com (AMZN) at 0.99 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

AMZN

Consumer Discretionary Distribution & Retail industry group

0.99

Max
2.62
Q3
1.75
Median
1.35
Q1
1.00
AMZN
0.99
Min
0.48
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Amazon.com (AMZN) carries debt-to-equity ratio of 0.50 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

AMZN

Consumer Discretionary Distribution & Retail industry group

0.50

Max
3.93
Q3
2.14
Median
1.25
Q1
0.73
AMZN
0.50
Min
0.01
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): ABBV does not report debt-to-equity ratio, so it has no value marker; AMZN is benchmarked against the Consumer Discretionary Distribution & Retail industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Current Ratio (MRQ)0.870.99
Debt / Equity (MRQ)--0.50
Net Debt / EBITDA2.211.04

Dividends

Dividend Yield (TTM)

Amazon.com (AMZN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile AbbVie (ABBV) reports a yield of 2.40%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

AMZN

Consumer Discretionary Distribution & Retail industry group

0.00%

Max
5.84%
Q3
2.50%
AMZN
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings; Amazon.com (AMZN) pays no dividend (payout 0.00%).

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

AMZN

Consumer Discretionary Distribution & Retail industry group

0.00%

Max
72.73%
Q3
32.44%
AMZN
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
Dividend Yield (TTM)2.40%0.00%
Dividend Payout Ratio (TTM)117.35%0.00%

Valuation

P/E Ratio (TTM)

Amazon.com (AMZN) at 20.96 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

AMZN

Consumer Discretionary Distribution & Retail industry group

20.96

Max
40.50
Q3
24.26
AMZN
20.96
Median
19.23
Q1
12.64
Min
4.67
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Amazon.com (AMZN) at 3.52 sits in the pricier quartile — AMZN costs more per dollar of sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

AMZN

Consumer Discretionary Distribution & Retail industry group

3.52

Max
4.32
AMZN
3.52
Q3
1.99
Median
0.70
Q1
0.26
Min
0.03
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Amazon.com (AMZN) reports 4.57, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

AMZN

Consumer Discretionary Distribution & Retail industry group

4.57

Max
10.96
Q3
5.26
AMZN
4.57
Median
2.16
Q1
1.08
Min
-4.45
Loading chart…
AbbVie (ABBV) vs. Amazon.com (AMZN): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Discretionary Distribution & Retail industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Amazon.com (AMZN)
MetricABBVAMZN
P/E Ratio (TTM)50.0520.96
P/S Ratio (TTM)7.803.52
P/B Ratio (MRQ)-112.344.57
Free Cash Flow Yield (TTM)3.44%-1.24%